“Time to embrace GMO” by Nuseed

Time to embrace GMO?

Biotechnology enables efficient and targeted development of biological resources to strengthen sustainability and resilience of the bioeconomy and food systems. Improved plant and animal health, climate adaption, increased yield and reduced land use, improved nutritional value in food and feed and improved animal welfare are among the benefits these technologies offer. However, realizing the potential of these technologies depends on the political and societal framework within which they exist. In Norway and Europe, regulations and consumer perception represent barriers to innovation and commercial use of genetically modified products (GMOs). Is it time to embrace GMO? This session aims to build knowledge about genetic engineering/GMO and address opportunities to facilitate its adoption in aquaculture and beyond.

After Sigrid Bratlie’s presentation, there will be a panel of industry leaders discussing the challenges and opportunities for GMO in aquaculture – panel list TBA.
Refreshments will be served.

Speakers

Sigrid Bratlie
Senior Advisor - Langsikt Policy Centre
Strategic Advisor - Norwegian Cancer Society

Sigrid Bratlie works at the intersection of science, communication, and policy in the field of biotechnology, spanning sectors such as medicine, industry, food systems, and environmental protection. She is currently a Senior Advisor at the Langsikt Policy Centre and a Strategic Advisor to the Norwegian Cancer Society. Previously, she has worked closely with Norwegian agriculture and aquaculture, serving as Project Leader at NCE Heidner Biocluster for bioeconomy and as a member of the GENEinnovate research consortium on genome editing. Sigrid has also worked for the Norwegian Biotechnology Advisory Board and was a member of Genteknologiutvalget, which delivered a Norwegian Official Report (NOU) to the government in 2023.

In addition to her professional roles, Sigrid is an active science communicator dedicated to raising public awareness about biotechnology’s potential to drive sustainable development and to advocating for evidence-based policymaking. She holds a degree in Molecular Biology from the University of Glasgow and Imperial College London, as well as a PhD from the Institute for Cancer Research at the Norwegian Radium Hospital, for which she was awarded the King’s Gold Medal.